|
|
|
Volumn 305, Issue 5687, 2004, Pages 1088-1089
|
|
Pediatric study of ADHD drug draws high-level public review
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHETAMINE;
METHYLPHENIDATE;
CENTRAL STIMULANT AGENT;
DEXAMPHETAMINE;
DRUG DEVELOPMENT;
ATTENTION DEFICIT DISORDER;
CONTROL GROUP;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MEDICAL ETHICS;
NOTE;
POLICY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
ADOLESCENT;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BRAIN;
CHILD;
CLINICAL TRIAL;
DRUG EFFECT;
ETHICS;
HEALTH CARE ORGANIZATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PROFESSIONAL STANDARD;
PUBLIC HEALTH SERVICE;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
ADOLESCENT;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BRAIN;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CLINICAL TRIALS;
DEXTROAMPHETAMINE;
ETHICS COMMITTEES, RESEARCH;
HUMANS;
MAGNETIC RESONANCE IMAGING;
METHYLPHENIDATE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
UNITED STATES OFFICE OF RESEARCH INTEGRITY;
|
|
EID: 4344644978
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|